Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Reddit Inc (RDDT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Reddit IncTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Reddit Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Reddit Inc trades at $146.94 (market cap $28.74B), while Regeneron Pharmaceuticals Inc trades at $808.33 (market cap $83.43B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.9× Reddit Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.46% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.

RDDTREGN
Market Cap
$28.74B$83.43B
Sector
MediaHealth
52-Week High
$270.71$852.03
52-Week Low
$121.84$555.51
Enterprise Value
$25.97B$78.14B
Dividend Yield
0.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Reddit Inc

Reddit (RDDT) trades at $149.38, down 3.29% amid bearish technical signals, though fundamentals remain strong with 61% YoY revenue growth and consistent earnings beats. The stock faces valuation concerns despite robust profitability margins above 30% and positive analyst sentiment with 64% buy ratings. Recent CEO stock sales and AI licensing renewal risks have contributed to recent volatility.

The outlook remains positive with a $216.08 consensus price target suggesting 45% upside potential, driven by AI monetization and international expansion. Key risks include valuation compression, competitive pressures in digital advertising, and the expiration of major AI data licensing agreements in 2027.

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals (REGN) trades at $810.31, down 2.1% today, with strong fundamentals including 84.9% gross margins and consistent earnings beats. The stock shows bullish technical signals with support at $805 and resistance at $838, while analyst consensus remains strongly positive with 69% buy ratings. Recent news highlights multiple class action lawsuits related to clinical trial disclosures, creating near-term sentiment headwinds despite solid financial performance.

Outlook remains cautiously optimistic given strong profitability and analyst support, though legal risks and clinical trial uncertainties present challenges. The stock trades above consensus price target of $756.82, suggesting limited near-term upside potential despite robust fundamentals and institutional confidence.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN